Publication | Closed Access

Modulation of the systemic inflammatory response by recombinant human interleukin-11: A prospective randomized placebo controlled clinical study in patients with hematological malignancy

InflammationCytokineRecombinant Human Interleukin-11Hematological MalignancyMedicineMalignant Blood DisorderImmunologyHematologyAutoimmunitySystemic Inflammatory ResponseCell TransplantationImmunotherapyOncologyRadiation OncologyHealth Sciences